Manis Medical Agencies

Rituximab belongs to a class of medications called monoclonal antibodies. It is used to treat non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL) and works by killing cancer cells. Certain rituximab injection brands also treat rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and pemphigus vulgaris by blocking the activity of the part of the immune system that may damage the joints, veins, and other blood vessels.

Rituximab is used in adults alone or with other medications to treat various types of non-Hodgkin's lymphoma (a type of cancer that begins in a type of white blood cells that normally fights infection).

Rituximab is also used in adults with other medications to treat chronic lymphocytic leukemia (a type of cancer of the white blood cells).

Rituximab (Rituxan, Ruxience, Truxima) is also used in adults with methotrexate (Otrexup, Rasuvo, Xatmep, others) to treat the symptoms of rheumatoid arthritis (RA; a condition in which the body attacks its own joints, causing pain, swelling, and loss of function) in adults who have already been treated with a certain type of medication called a tumor necrosis factor (TNF) inhibitor.

Rituximab (Rituxan, Riabni, Ruxience, Truxima) is also used in adults and children 2 years of age and older along with other medications to treat granulomatosis with polyangiitis (Wegener's granulomatosis) and microscopic polyangiitis, which are conditions in which the body attacks its own veins and other blood vessels, which causes damage to organs, such as the heart and lungs.

Rituximab injection (Rituxan) is used to treat pemphigus vulgaris (a condition that causes painful blisters on the skin and the lining the mouth, nose, throat and genitals).

• Breast cancer
• Non-small cell lung cancer
• Prostate cancer
• Cancer of head and neck

Kinaplat 50mg Injection belongs to the group of medications called platinum-based antineoplastic agents. It consists of the active ingredient Oxaliplatin. It is prescribed to treat stage 3 colon cancer after resectioning (surgical removal) of the primary tumor, metastatic colon and rectum cancer.

Iron sucrose injection comes as a solution (liquid) to inject intravenously (into a vein) by a doctor or nurse in a medical office or hospital outpatient clinic. It is usually injected over 2 to 5 minutes or may be mixed with another fluid and infused slowly over 15 minutes to 4 hours depending on your dose of medication. Your doctor will determine how often you receive iron sucrose injection and your total number of doses based on your condition and how well you respond to the medication. If your iron levels become low after you finish your treatment, your doctor may prescribe this medication again.

Iron sucrose injection may cause severe or life-threatening reactions while you receive the medication. Your doctor will watch you carefully while you receive each dose of iron sucrose injection and for at least 30 minutes afterwards. Tell your doctor if you experience any of the following symptoms during or after your injection: shortness of breath; difficulty swallowing or breathing; hoarseness; swelling of the face, throat, tongue, lips, or eyes; hives; itching; rash; fainting; lightheadedness; dizziness; cold, clammy skin; rapid, weak pulse; slow heartbeat; headache; nausea; vomiting; joint or muscle pain; stomach pain; pain, burning, numbness, or tingling in the hands or feet; swelling of the hands, feet, ankles, or lower legs; loss of consciousness; or seizures. If you experience a severe reaction, your doctor will slow or stop your infusion immediately and provide emergency medical treatment.